Definium Therapeutics, Inc. is 2.5x more valuable than Cronos Group Inc. by market capitalization ($2.53 B vs $1.03 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CRON | DFTX |
|---|---|---|
| Market cap | $1.03 B | $2.53 B |
| US-listed rank | #2610 | #1939 |
| Revenue (latest FY) | $146.59M | - |
| Net income (latest FY) | -$2.90M | -$183.79M |
| Net margin | -2.0% | - |
| SEC filings | 486 | 445 |
Definium Therapeutics, Inc. is 2.5x more valuable than Cronos Group Inc. by market capitalization ($2.53 B vs $1.03 B).
Full pages: Cronos Group Inc. and Definium Therapeutics, Inc., or browse the full rankings.